Table 6

Management and outcomes of patients admitted to PMH/PCH in 2018

TotalPeriorbitalOther
(n=206)(n=46)(n=160)
Duration of intravenous antibiotics, days, median (IQR)2 (2–3)3 (2–3)2 (2–3)
Intravenous antibiotic, n (%)n=199n=45n=154
 Flucloxacillin154 (77.4)41 (91.1)113 (73.3)
 Cefotaxime2 (1.0)2 (4.4)
 Ceftriaxone47 (23.6)41 (91.1)6 (3.9)
 Cefazolin38 (19.1)5 (11.1)33 (21.4)
 Clindamycin10 (5.0)10 (6.5)
 Cotrimoxazole2 (1.0)2 (1.3)
 Benzylpenicillin1 (0.5)1 (0.6)
 Piperacillin/tazobactam15 (7.5)4 (8.9)11 (7.1)
 Vancomycin27 (13.6)2 (4.4)25 (16.2)
 Other3 (1.5)3 (1.9)
Duration of oral antibiotics, days, median (IQR)6 (5–7)7 (5–8)5 (5–7)
Oral antibiotic on discharge, n (%)n=192n=42n=150
 Flucloxacillin20 (10.4)1 (2.4)19 (12.7)
 Cephalexin103 (53.6)13 (30.9)90 (60.0)
 Clindamycin8 (4.2)1 (2.4)7 (4.7)
 Cotrimoxazole20 (10.4)2 (4.8)18 (12.0)
 Amox/clav duo forte37 (19.3)24 (57.1)13 (8.7)
 Amoxicillin2 (1.0)1 (2.4)1 (0.7)
 Other4 (2.1)4 (2.7)
Total duration of antibiotic therapy, median (IQR)8 (7–10)9 (8–11)8 (7–10)
Surgery, n (%)52 (25.2)52 (32.5)
Duration of admission, median (IQR)3 (2–4)3 (2–4)3 (2–4)
Discharged to HITH, n (%)16 (7.8)9 (19.6)7 (4.4)
Follow up with paediatrician documented, n (%)80 (38.8)15 (32.6)65 (40.6)
  • HITH, hospital in the home; PCH, Perth Children’s Hospital; PMH, Princess Margaret Hospital for Children.